Cargando…

Correlation of Serum IGF-1R, VEGF, and ET Levels with Bone Mineral Density in Type 2 Diabetic Mellitus Patients Treated with Metformin Plus α-Glucosidase Inhibitors

Diabetes mellitus is a common chronic disease. This study aimed to investigate the correlation between serum insulin-like growth factor 1 receptor (IGF-1R), vascular endothelial growth factor (VEGF), endothelin (ET) levels, and bone mineral density (BMD) in type 2 diabetic mellitus (T2DM) patients t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xue, Li, Xiaosheng, Kang, Sheng, Duan, Wenbiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050299/ https://www.ncbi.nlm.nih.gov/pubmed/35497918 http://dx.doi.org/10.1155/2022/7707875

Ejemplares similares

Investigation of Anthocyanidins and Anthocyanins for Targeting α-Glucosidase in Diabetes Mellitus
por: Promyos, Natnicha, et al.
Publicado: (2020)

Exploring the inhibitory mechanism of piceatannol on α-glucosidase relevant to diabetes mellitus
por: Jiang, Lili, et al.
Publicado: (2020)

Randomized controlled clinical trial of a combination therapy of vildagliptin plus an α-glucosidase inhibitor for patients with type II diabetes mellitus
por: SU, YONG, et al.
Publicado: (2014)

A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus
por: Tandon, Tanya, et al.
Publicado: (2019)

Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus
por: Wang, Lin-Xia, et al.
Publicado: (2020)

Fishing of α-Glucosidase’s Ligands from Aloe vera by α-Glucosidase Functionalized Magnetic Nanoparticles
por: Yuan, Hao, et al.
Publicado: (2021)

Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
por: Loh, Darren Kin Wai, et al.
Publicado: (2022)

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel Isatin-Thiazole Derivatives as α-Glucosidase Inhibitors
por: Xie, Zhenzhen, et al.
Publicado: (2017)

Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
Publicado: (2013)

Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study
por: Chen, Yulong, et al.
Publicado: (2019)

Comparative Evaluation of the Antiglycation and Anti-α-Glucosidase Activities of Baicalein, Baicalin (Baicalein 7-O-Glucuronide) and the Antidiabetic Drug Metformin
por: Froldi, Guglielmina, et al.
Publicado: (2022)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

VEGF-A, VEGF-C, VEGF-R2, EGFR and HER2 in serum plus EGFR in tissue of patients with triple-negative breast cancer
por: Iosifidou, R, et al.
Publicado: (2009)

Serum ferritin levels and bone mineral density in the elderly
por: Babaei, Mansour, et al.
Publicado: (2018)

Initial combination therapy for patients with type 2 diabetes mellitus: considerations for metformin plus linagliptin
por: Freeman, Jeffrey S
Publicado: (2013)

Momilactones A and B Are α-Amylase and α-Glucosidase Inhibitors
por: Quan, Nguyen Van, et al.
Publicado: (2019)

Dietary Polyphenols as Natural Inhibitors of α-Amylase and α-Glucosidase
por: Ćorković, Ina, et al.
Publicado: (2022)

Effects of Glimepiride Combined with Recombinant Human Insulin Injection on Serum IGF-1, VEGF and TRACP-5b Oxidative Stress Levels in Patients with Type 2 Diabetes Mellitus
por: Chen, Xue, et al.
Publicado: (2022)

α-Glucosidase inhibitors and their use in clinical practice
por: Derosa, Giuseppe, et al.
Publicado: (2012)

α-Glucosidase Inhibitors from Vauquelinia corymbosa
por: Flores-Bocanegra, Laura, et al.
Publicado: (2015)

Characterizing the selectivity of ER α-glucosidase inhibitors
por: O’Keefe, Sarah, et al.
Publicado: (2019)

Flavonoids as Human Intestinal α-Glucosidase Inhibitors
por: Barber, Elizabeth, et al.
Publicado: (2021)

Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients
por: Wang, Fei, et al.
Publicado: (2017)

Nuclear receptor and VEGF pathways for gene-blood lead interactions, on bone mineral density, in Korean smokers
por: Lee, Ho-Sun, et al.
Publicado: (2018)

Higher Serum Uric Acid Is Associated with Higher Bone Mineral Density in Chinese Men with Type 2 Diabetes Mellitus
por: Zhao, Dian-dian, et al.
Publicado: (2016)

Clinical Diagnostic Value of Serum GABA, NE, ET-1, and VEGF in Chronic Obstructive Pulmonary Disease with Pulmonary Hypertension
por: Yan, Jing, et al.
Publicado: (2023)

Bone mineral density evaluation of patients with type 2 diabetes mellitus
por: Adil, Camli, et al.
Publicado: (2015)

Serum minerals (Ca, P, Co, Mn, Ni, Cd) and growth hormone (IGF-1 and IGF-2) levels in postmenopausal Saudi women with osteoporosis
por: Yakout, Sobhy M., et al.
Publicado: (2020)

Effects of metformin on bone mineral density and bone turnover markers: a systematic review and meta-analysis
por: Hu, Jinhua, et al.
Publicado: (2023)

First pregnancy events and future breast density: modification by age at first pregnancy and specific VEGF and IGF1R gene variants
por: Prebil, Lee Ann, et al.
Publicado: (2014)

Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus
por: Zhao, Chenhe, et al.
Publicado: (2019)

Evaluation of Bone Mineral Density, Serum Osteocalcin, and Osteopontin Levels in Postmenopausal Women with Type 2 Diabetes Mellitus, with/without Osteoporosis
por: Roomi, Ali B., et al.
Publicado: (2022)

The polymorphism of Insulin-like growth factor-I (IGF-I) is related to osteoporosis and bone mineral density in postmenopausal population
por: Yun-Kai, Li, et al.
Publicado: (2014)

Diosgenin from Dioscorea bulbifera: Novel Hit for Treatment of Type II Diabetes Mellitus with Inhibitory Activity against α-Amylase and α-Glucosidase
por: Ghosh, Sougata, et al.
Publicado: (2014)

QSAR Studies on Andrographolide Derivatives as α-Glucosidase Inhibitors
por: Xu, Jun, et al.
Publicado: (2010)

α-Glucosidase inhibitors from the bark of Mangifera mekongensis
por: Nguyen, Hai Xuan, et al.
Publicado: (2016)

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors
por: Kalra, Sanjay, et al.
Publicado: (2014)

In Vitro and In Vivo Effects of Norathyriol and Mangiferin on α-Glucosidase
por: Shi, Zhi-Long, et al.
Publicado: (2017)

α-Glucosidase Inhibitory Activity of Selected Malaysian Plants
por: Mohd Bukhari, Dzatil Awanis, et al.
Publicado: (2017)

Effects of Synergistic Inhibition on α-glucosidase by Phytoalexins in Soybeans
por: Son, Hyeong-U, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jrh615mse81i45cuha23ea6653